Stock BIOSIGN TECHNOLOGIES INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Insiders Biosign Technologies Inc Other OTC

Equities

CA09070P1009

End-of-day quote Other OTC
Other stock markets
- USD - Intraday chart for Biosign Technologies Inc
2016 Quob Park Estate Ltd cancelled the acquisition of 70% stake in Aiomed GmbH from Biosign Technologies Inc.. CI
2016 Quob Park Estate Ltd signed a letter of intent to acquire 70% stake in Aiomed GmbH from Biosign Technologies Inc. for €3.2 million. CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Brian Neill Resigns from the Board of Biosign Technologies Inc
CI
Biosign Technologies Inc. Announces Management Changes
CI
Biosign Technologies Inc. Announces the Appointment of Ron Kelusky to its Board
CI
Biosign Technologies Inc. Announces Resignation of John-Peter Bradford from Its Board, Effective from June 27, 2014
CI
Biosign Technologies Inc. Announces Resignation of Tony Melles from its Board, Effective June 13, 2014
CI
Biosign Technologies Inc. Appoints Tony Melles as Board of Director
CI
Biosign Technologies Inc. Appoints Michael Gross to its Board of Directors
CI
Biosign Technologies Inc. Announces Executive Changes
CI
Biosign Technologies Inc. Appoints Peter Hamilton as Executive Vice President of Business Development, Effective January 1, 2013
CI
Biosign Technologies Inc. Announces Executive Changes
CI
Biosign Technologies Inc. Enters into Two Loan Agreements; Appoints Scott Jenkins to the Board of Directors
CI
Biosign Technologies Inc. Announces Resignation of Steven Bloom as Director
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BITKF Stock
  4. Stock
  5. News Biosign Technologies Inc
  6. Insiders